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Abstract
Background: Orthostatic hypotension (OH) is a common problem among the elderly. It is associated
with an increase in morbidity and mortality, but its prevalence in Mexico is unknown.
Methods: We conducted a cross-sectional prospective study of intern patients at several Mexi-
can elderly assistance institutions. We carried out a history and took blood pressure readings in
a seated position, immediately after standing up, and again after 3 min of standing up.
Results: We evaluated 132 patients, mean age 82.3 ± 9.5 years, 74.1% of them female.
Thirty-nine (29.3%) subjects had OH. They had a higher prevalence of hypothyroidism, Par-
kinson’s disease, depression and alcoholism. Their Minimental result was 15.45 ± 7.2 vs
16.12 ± 7.9 (p = 0.6) among those without OH, and their quality of life (Minnesota scale) was
12.1 ± 7.3 vs 9.15 ± 7.05 (p = 0.03). They used more ACEI, digoxin and levothyroxin.
Hypertension and alcoholism showed respectively a RR of 2.6 (95% CI 0.9–7.6, p = 0.06) and
3.18 (95% CI 0.96–10.48, p = 0.05) to develop OH.
Conclusions: OH was present in 29.3% of the studied population. A third of them had
hypertension. The use of different medications does not solely explain OH, so it is necessary to
look for different associations. Among those, chronic alcoholism stands out. OH is associated
with a poorer quality of life and cognitive performance. OH is asymptomatic in most cases.
(Cardiol J 2011; 18, 3: 282–288)
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Introduction
Orthostatic hypotension (OH) is a relatively
common finding in elderly people. It has been cal-
culated that 15–55% of the residents of a retirement
home may have an abnormal blood pressure (BP)
regulation [1–4]. These BP changes can be related
to many factors.
Older patients show several changes in the
complex autonomic regulation of BP as part of the
adaptations related to ageing. They show an in-
crease in plasma norepinephrine levels and a de-
crease in beta-adrenergic receptors sensitivity.
There is also a reduction in the alpha-mediated va-
somotor response, a lower baroreflex sensitivity and
parasympathetic tone. These complex interactions
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occur in a stiff vascular system influenced by endo-
thelins, a decay in nitric oxide production and ath-
erosclerosis. At the heart level, there is a reduction
in pacemaker cells in the sinus node, and a worse
calcium re-uptake that induces abnormal ventricu-
lar relaxation. All these conditions facilitate neurally
mediated syncope or dysautonomic reflexes [3, 5, 6].
Older people are prone to the autonomic dysfunctions
induced by chronic illnesses such as diabetes, Par-
kinson’s disease or pure autonomic failure.
Older people commonly use several medica-
tions, especially anti-hypertensive drugs, since
hypertension affects 30% of Mexico’s adult popu-
lation according to national surveys [7, 8].
Some studies in assistance facilities or retire-
ment homes have shown a mean of 3.5 chronic il-
lnesses per person. And at least one third of peo-
ple aged above 65 routinely use three different med-
ications. A recent study showed that these numbers
can go up to 6.1 ± 2.6 drugs, of which 4.7 ± 1.9 are
potentially fall-inducers [3, 9–12].
Some studies have been able to relate frequent
falls to OH, although there are contradictory results
regarding the specific role of OH as a fall risk factor.
Some authors suggest that the frequency of both
problems is so high that even a multifactorial analy-
sis could not find a significant risk increase [3, 9].
There is evidence that OH is also associated
with an increase in the risk for stroke or brain vas-
cular disease, nocturnal hypertension, myocardial
infarction and accelerated atherosclerosis [1, 13–
–16]. All these risks jeopardize the patient’s quali-
ty of life (QoL), something that can also be influ-
enced by OH symptoms themselves.
OH detection is important in terms of preven-
tion, since only 25% of patients show any symptoms.
So falls or other QoL-compromising conditions can
be wrongly attributed to different diseases [17].
Although there is disagreement regarding OH
definition, the most widely accepted one is a reduc-
tion of 20 mm Hg in systolic BP or a 10 mm Hg re-
duction in the diastolic record in the first three
stand-up minutes [17–19].
In Mexico there have been several studies
aimed at the evaluation of hypertension treatment.
OH appears as a complication of such treatment, but
we don’t know the specific features of OH as an
autonomic dysfunction. Our study is the first at-
tempt to establish OH prevalence in our country.
Methods
We conducted a cross-sectional prospective
study to identify OH in elderly adults in public or
private care institutions, which were selected ac-
cording to their willingness to collaborate in our
study. Every adult older than 65 years of age who
was a resident of any of the participating institutions
and signed an informed consent (approved by the
University’s Ethics Committee) was included in the
study. If the patient had a mild degree of dementia
that did not preclude a convenient information re-
trieval, or if they had a complete hospital record
they were also included in the study.
People with an incomplete history, or who were
incapable of answering questions regarding their
history or quality of life or Minimental, or of remaining
standing for 3 min, were excluded from the study.
We excluded anyone with an incapacitating
dementia that precluded history taking or preclu-
ded an adequate comprehension of what was in-
volved in giving informed consent.
Once the informed consent was signed and his-
tory data completed (from interrogation and insti-
tutional records), we performed the BP measure-
ments using aneroid oscillometric sphygmomano-
meters previously calibrated with mercury equipment.
Researchers performed the measurements with
a standardized technique according to the JNC VII
and national guidelines [19, 20].
Basal lectures were recorded in a seated posi-
tion (after at least five minutes’ rest), and then af-
ter one minute of standing up and after three min-
utes of standing up. We diagnosed orthostatic hy-
potension when there was a drop in systolic BP
equal to or higher than 20 mm Hg, a diastolic fall
equal to or higher than 10 mm Hg, or where there
was a combination of both.
We express continuous variables as means ±
± standard deviation and categorical variables as
percentages. We used Student’s T for comparisons,
as well as c2. A logistic regression analysis was made
to search for possible risk associations.
Results
We evaluated 135 intern patients of several
publicly- and privately-run elderly assistance insti-
tutions in the city of Querétaro. Three cases were
excluded from analysis because they couldn’t sus-
tain standing up for 3 min. The mean age of the
group was 82.35 ± 9.5 years and 100 (74.1%) were
female. Thirty-nine (29.3%) cases had OH. Of these,
11 had both systolic and diastolic hypotension, while
the others had either systolic or diastolic hypoten-
sion. In nine (6.7%) cases there was a BP reduction
higher than 16 mm Hg but less than 20 mm Hg, with-
out significant diastolic changes but with associated
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symptoms. We did not include these patients in the
OH group. Table 1 shows the main characteristics
of the OH group and the other patients.
The same table shows that patients with OH
had a higher prevalence of hypothyroidism, Parkin-
son’s disease, depression and chronic alcohol con-
sumption, even if the differences were non-significant.
Patients without OH had a higher prevalence of is-
chemic heart disease, diabetes, cancer and syncope.
Table 2 shows the main Minimental and Min-
nesota Quality of Life (QoL) scores. In both scales,
patients with OH perform more poorly than non-OH
patients. The significant differences, however, are
present in general QoL, and specifically in the pain
measure. Sleep quality is also worse in subjects with
OH, although it does not reach statistical signifi-
cance.
Table 3 shows the changes in mean systolic and
diastolic BP. Significant differences were found
between the non-OH individuals at the first stand-
up minute.
Table 4 shows the main symptoms associated
with stand-up time. There are some differences in
the presence of nausea, weakness and syncope in
the third minute, although they don’t reach statis-
tical significance.
We checked the number of medications and co-
morbidities in each group. Patients with OH used
Table 2. Minimental and Minnesota Quality of Life (QoL) scores.
Orthostatic hypotension Non-orthostatic hypotension P
N 39 (29.3%) 94 (70.7%)
Minimental 15.45 ± 7.2 16.12 ± 7.9 0.6
Total QoL score 12.1 ± 7.3 9.15 ± 7.05 0.03
Energy 0.89 ± 1.1 0.58 ± 0.9 0.1
Pain 2.7 ± 2.5 1.7 ± 2.2 0.03
Emotional 1.9 ± 2.2 1.4 ± 1.9 0.5
Sleep 1.6 ± 1.6 1.06 ± 1.4 0.08
Social isolation 1.1 ± 1.2 1.07 ± 1.3 0.9
Physical activity 3.8 ± 2.3 3.2 ± 2.5 0.2
Table 1. Main characteristics and history.
Orthostatic hypotension Non-orthostatic hypotension P
N 39 (29.3%) 94 (70.7%)
Age (years) 83.3 ± 9.4 82.2 ± 9.5 0.5
Gender (female) 30 (76.9%) 68 (72.3%) 0.5
Hypertension 14 (35.9%) 33 (35.5%) 0.9
Diabetes 4 (10.3%) 22 (23.7%) 0.07
Myocardial ischemia 1 (2.6%) 5 (5.4%) 0.4
Stroke 3 (7.7%) 4 (4.3%) 0.4
Renal failure 0 1 (1.1%) 0.5
Hypothyroidism 3 (7.7%) 2 (2.2%) 0.1
Cancer 0 3 (3.2%) 0.2
Syncope 1 (2.6%) 3 (3.2%) 0.8
Falls 13 (33.3%) 34 (36.6%) 0.8
Liver disease 0 1 (1.1%) 0.5
Vascular dementia 10 (25.6%) 22 (23.4%) 0.7
Alzheimer’s 1 (2.6%) 2 (2.1%) 0.8
Parkinson’s 3 (7.7%) 4 (4.3%) 0.4
Depression 4 (10.3%) 7 (7.4%) 0.6
Alcoholism 7 (17.9%) 10 (10.6%) 0.3
Smoking 11 (28.2%) 20 (21.3%) 0.2
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1.72 ± 2 drugs, while subjects without OH used
2.67 ± 2.5 (p = 0.07). There were patients who did
not use any medication at all, and patients who used
up to ten different compounds. Table 4 shows the
medications more used by these patients and the
differences among both groups. In the OH group,
ten (25.6%) patients used more than three medica-
tions. In the non-OH group, 45 (47.9%) (p = 0.01)
patients did so.
In the OH group, the mean co-morbidities
present was 1.56 ± 1.02, and in the non-OH group
it was 1.9 ± 1.18 (p = 0.5).
Finally, we conducted a backwards step-by-
-step multivariate logistic regression analysis to
evaluate the findings where there were significant
differences (or nearly significant). The elements
associated with an increased risk for OH were hy-
Table 4. Symptoms related to position changes (sitting–standing).
Symptom Orthostatic hypotension Non-orthostatic hypotension P
Baseline dizziness or vertigo 2 (5.1%) 4 (4.3%) 0.5
1st stand up min. dizziness 1 (2.6%) 3 (3.2%) 0.6
3rd stand up min. dizziness 3 (7.7%) 7 (7.5%) 0.6
Baseline nausea 1 (2.6%) 1 (1.1%) 0.5
1st stand up min. nausea 0 1 (1.1%) 0.7
3rd stand up min. nausea 1 (2.6%) 1 (1.1%) 0.5
Baseline diaphoresis 0 0 0.7
1st stand up min. diaphoresis 0 0 0.7
3rd stand up min. diaphoresis 1 (2.6%) 2 (2.1%) 0.6
Baseline weakness 4 (10.3%) 8 (8.5%) 0.4
1st stand up min. weakness 5 (12.8%) 12 (12.8%) 0.5
3rd stand up min. weakness 9 (23.1%) 14 (15.4%) 0.1
Baseline syncope 0 0 0.5
1st stand up min. syncope 0 0 0.5
3rd stand up min. syncope 1 (2.6%) 0 0.5
Table 3. Blood pressure changes.
OH p (OH vs non-OH) Non-OH
Baseline SBP 129.7 ± 18.6 0.14 124.6 ± 16.7
Min 1 SBP 112.7 ± 18.3 0.01 121.9 ± 18.9
p (baseline vs min 1) > 0.0001 – 0.03
Min 3 SBP 119.5 ± 19.3 0.2 123.6 ± 17.8
p (baseline vs min 3) 0.001 – 0.6
Baseline DBP 75.9 ± 15.02 0.04 70.3 ± 10.9
Min 1 DBP 67.3 ± 12.1 0.03 72.5 ± 12.6
p (baseline vs min 1) > 0.0001 – 0.01
Min 3 DBP 70.6 ± 13.8 0.2 73.7 ± 13.7
p (baseline vs min 3) 0.004 – 0.1
pertension, (RR 2.6, 95% CI 0.9–7.6, p = 0.06) and
chronic alcohol intake (3.18 95% CI 0.96–10.48,
p = 0.05). Other variables were discarded in the
first steps. Even if they seemed clinically relevant,
none was statistically significant.
Discussion
The prevalence of OH in this series is within
the ranges found in other studies. Many of our pa-
tients have relatively little co-morbidity and use
a small number of medications, compared to the find-
ings by other authors, even if they are older [9–12].
Among the most prevalent co-morbidities in
the OH group, there are several diseases known
because of their potential effect on the autonomic
nervous system, such as Parkinson’s disease and
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depression, although in the non-OH group diabe-
tes is more prevalent, a disease that shows among
its neuropathic complications autonomic dysfunc-
tion [21–27]. We must consider that the most usu-
al manifestations of diabetic dysautonomic beha-
vior are related to an increase in the baseline heart
rate and a decrease in heart rate variability [27].
This higher prevalence of diabetes explains the dif-
ference regarding the use of biguanides and sulfo-
nylureas in the non-OH group. We will discuss
medications later, but there is no apparent relation-
ship between hypoglucemiant drugs and dysauto-
nomic reflexes, although there is some antiarrhyth-
mic potential for sulfonylureas.
A national registry found an incidence of 10%
of OH among patients with Parkinson’s disease [21].
In our series, 7.7% of the subjects with OH had
Parkinson’s.
Chronic alcohol intake is an interesting find-
ing because even if the difference is non-significant,
it appears to be clinically relevant, as shown by the
logistic regression analysis. It is known that acute
alcohol intake is related to high BP, but there is lit-
tle information regarding chronic use or abuse of al-
cohol and autonomic dysfunction [28, 29]. Subclini-
cal abnormalities can be detected by sympathetic
cutaneous response, and some patients might also
have OH, even after ceasing to drink [29, 30]. This
supports our findings, but we must remember that
only 17% of our patients with OH had a history of
chronic alcohol abuse.
Both the Minimental and Minnesota QoL
scores were worse in the OH group. It is possible
that repeated episodes of hypotension might make
vascular dementia symptoms more evident. As shown
in Table 1, the proportion of patients with vascular
dementia (diagnosed at the assistance center) is
slightly higher in the OH group. This might explain
the differences in the Minimental score. The study’s
design does not allow the establishment of whether
OH is a causative factor for vascular dementia.
Hypertension is an element that does not show
significant differences regarding proportions, but
logistic regression analysis suggests that it might
be an important risk factor for OH.
Another study has demonstrated that hyper-
tensive subjects show a close relationship between
the level of BP control and their Minimental score.
In other words, worse BP control is associated with
a worse Minimental score [32]. Nonetheless, the
same study showed that such a correlation is lost
in people over the age of 80. In our series, the mean
age is above 80 years, a factor that could influence
the test’s results. Possibly a larger series could elicit
a better discrimination.
Regarding QoL, the differences between
groups are significant and this suggests that OH-
-related symptoms might be more severe than pre-
viously thought. Chronic pain has been related to
different manifestations of autonomic dysfunction.
A relevant syndrome such as fibromyalgia has been
related to neurocardiogenic syncope, an autonomic
dysfunction of the same ‘family’ as orthostatic hy-
potension, i.e. the neurally mediated syncopes
[6, 33–39] but none of these patients had diagnosed
fibromyalgia. There have been many publications
regarding the effect of chronic inflammatory diseas-
es (lupus, rheumatoid arthritis, schleroderma) on
the autonomic function, but whether chronic arthro-
sis pain has some effect on autonomic regulation has
not been described to our knowledge.
It is difficult to explain the differences regard-
ing sleep quality. Several diseases such as Parkin-
son’s are related to sleep disorders and they show
a dysautonomic behavior, in the same way that some
medications are able to induce OH and sleep disor-
ders. Risperidone, for example, is frequently asso-
ciated with OH, but only two subjects in our series
were using it [40–42].
Regarding pharmacological treatments, our
group showed great heterogeneity. Some patients
used no medications at all, while some used up to
ten different drugs, even if the mean quantity of
drugs is lower than that reported by other authors
[9, 11]. Perhaps this regulation of drug use is relat-
ed to the care provided by geriatric specialists in
the studied institutions. Polypharmacy is a common
phenomenon addressed by gerontologists [43–48].
Even if there were no significant differences, the
OH group used fewer diuretics, dehydropiridinic
calcium channel blockers and benzodiazepines, but
they used more angiotensin converting enzime in-
hibitors (ACEI), digoxin and levothyroxine. The
ACEI group has the potential to induce OH, and
nearly  a third of our patients used them. The group
without OH used more beta-blocking agents, non-
-steroidal anti-inflammatory drugs (NSAIDs), vita-
mins and glucose-lowering drugs. Both OH and non-
-OH groups used potentially OH inducing drugs, al-
though the non-OH group used more serotonin re-
uptake inhibitors and beta-blockers (drugs
commonly used in the treatment of neurally media-
ted syncope) even if their benefit is questionable
in such a context [6, 48, 49]. These patients with-
out OH used more NSAIDs, that are related to high
BP. Even if the mean BP measurements are within
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normal limits, the use of NSAIDs may somehow
contribute to avoiding OH [50, 51]. An apparently
paradoxical observation is that diuretics are less
common in the OH group [52, 53]. This possibly has
to do with the fact that OH itself, or the patient’s
age, are facts to consider when giving anti-hyper-
tensive treatment in these medically supervised
facilities. Even in the presence of several signifi-
cant differences regarding druguse between groups,
logistic regression analysis did not show any pos-
sible causative relationship.
Regarding symptoms, we selected the ones in
Table 3 because in previous works we had found that
nausea, dizziness and diaphoresis were associated
with a higher risk of having a positive Head-Up Tilt
Test (HUTT) [54–56]. Even if the OH diagnosis is
clinical and does not require HUTT, it shares some
features with the commonest cause of autonomic
dysfunction i.e. neurally mediated syncope [6]. We
found no significant differences (possibly because of
the number of patients) except for weakness percep-
tion and syncope in the third minute. Symptom ab-
sence is an important feature from a clinical stand-
point, since this could explain a certain number of
the falls referred to by the patients in their history
and supports other authors’ findings [9–11]. This
finding also implies the need to implement or rein-
force fall-related lesions prevention, since the ab-
sence of symptoms makes accidents more plausible.
Limitations of the study
Our main limitation was the number of patients,
even though we included people from several insti-
tutions. Even with different sorts of populations, the
measurement tools and data capture were the same.
Conclusions
Orthostatic hypotension was present in nearly
30% of the studied population. Among these sub-
jects, one third had hypertension, which is a risk
factor to develop OH. Medication use can hardly
explain OH in our group, so it is necessary to look
for other associations, and among them, chronic
alcohol consumption is a striking one.
Orthostatic hypotension implies worse QoL
scores and is also associated with poorer cognitive
functions, so it is important to prevent or avoid it,
as well as to treat it promptly, in order to avoid this
negative impact on QoL. Symptoms do not seem to
be a relevant factor in QoL, since many patients are
asymptomatic. This condition should prompt the
establishment or reinforcement of preventative
measures to avoid falls and fall-related injuries.
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